International Journal of Cardiology
Volume 136, Issue 2 , Pages 144-150 , 14 August 2009

N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I–II systolic heart failure

  • Frank Lloyd Dini

      Affiliations

    • Unità Operativa Malattie Cardiovascolari 2, Ospedale S. Chiara, Azienda Ospedaliera-Universitaria Pisana, Via Roma, 67, 56126, Pisa, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 050 992355; fax: +39 050 993114.
    • ,
  • Paolo Fontanive

      Affiliations

    • Unità Operativa Malattie Cardiovascolari 2, Ospedale S. Chiara, Azienda Ospedaliera-Universitaria Pisana, Via Roma, 67, 56126, Pisa, Italy
    • ,
  • Simona Buralli

      Affiliations

    • Dipartimento di Medicina Interna, Università di Pisa, Italia
    • ,
  • Erica Panicucci

      Affiliations

    • Dipartimento di Patologia Sperimentale, Tecnologie Biomediche ed Epidemiologia, Università di Pisa, Italia
    • ,
  • Diana Andreini

      Affiliations

    • Unità Operativa Malattie Cardiovascolari 2, Ospedale S. Chiara, Azienda Ospedaliera-Universitaria Pisana, Via Roma, 67, 56126, Pisa, Italy
    • ,
  • Umberto Conti

      Affiliations

    • Unità Operativa Malattie Cardiovascolari 2, Ospedale S. Chiara, Azienda Ospedaliera-Universitaria Pisana, Via Roma, 67, 56126, Pisa, Italy
    • ,
  • Salvatore Mario De Tommasi

      Affiliations

    • Unità Operativa Malattie Cardiovascolari 2, Ospedale S. Chiara, Azienda Ospedaliera-Universitaria Pisana, Via Roma, 67, 56126, Pisa, Italy

Received 23 October 2007 ,Revised 18 March 2008 ,Accepted 23 April 2008.

References 

  1. Hunt SA. American College of Cardiology; American heart Association Task Force on Practice Guidelines: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:1–82
  2. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:84–88
  3. Chakko S, Woska D, Martinez H, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90:353–359
  4. Ammar K, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115:1563–1570
  5. Dokainish H, Zoghbi WA, Lakkis NM, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol. 2004;45:1223–1226
  6. Bruch C, Rothenburger M, Gotzmann M, et al. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. J Am Soc Echocardiogr. 2006;19:522–528
  7. Lim TK, Hayat SA, Gaze D, Celik E, Collison P, Senior R. Independent value of echocardiography and N-terminal pro-natriuretic peptide for the prediction of major outcomes in patients with suspected heart failure. Am J Cardiol. 2007;100:870–875
  8. Lang RM, Bierig M, Deveraux RB. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108
  9. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987;75:175–183
  10. Hall S, Brickner M, Willet D, et al. Assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta. Circulation. 1997;95:636–642
  11. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is clinician's Rosetta stone. J Am Coll Cardiol. 1997;30:8–18
  12. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiographic and tissue Doppler in the estimation of left ventricular filling pressures. Circulation. 2000;102:1788–1794
  13. McAlister FA, Teo KK, Taher M, et al. Insights into contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 1999;138:87–94
  14. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J. 2002;23:1804–1806
  15. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with or without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724–1729
  16. Stevenson LW, Tillisch JH, Hamilton M, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction < 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1990;66:1348–1354
  17. Johnson W, Omland T, Hall C, et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol. 2002;39:1623–1629
  18. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797–1804
  19. Parthenakis FI, Kanoupakis EM, Kochiadakis GE, et al. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure. Am Heart J. 2000;140:338–344
  20. Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J. 1999;20:1799–1807
  21. Gardner RS, Ozalp E, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003;24:1735–1743
  22. Bayes-Genis A, Pascual-Figal D, Fabregat J, et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol. 2007;120:338–343
  23. Bettencourt P, Azevedo A, Fonseca L, et al. Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. Int J Cardiol. 2007;117:75–79
  24. Werner GS, Shafer C, Dirks R, Figulla HR, Kreuzer H. Prognostic value of Doppler echocardiographic assessment of left ventricular filling in dilated cardiomyopathy. Am J Cardiol. 1994;73:792–798
  25. Xie GY, Berk MR, Smith MD, et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 1994;24:132–139
  26. Pozzoli M, Traversi E, Cioffi G, Stenner R, Sanarico M, Tavazzi L. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation. 1997;95:1222–1230
  27. Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41:820–826
  28. Hillis GS, Moller JE, Pellikka P, et al. Non invasive estimation of left ventricular filling pressure by E/E′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2004;43:360–367
  29. Acil T, Wichter T, Stypmann J, et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure. Int J Cardiol. 2005;103:175–181
  30. Traversi E, Pozzoli M, Cioffi G, et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J. 1996;132:809–819
  31. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous sign. J Am Coll Cardiol. 1997;29:604–612
  32. Temporelli PL, Corrà U, Imparato A, Bosimini E, Scapellato F, Giannuzzi P. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts more favorable prognosis in patients with chronic heart failure. J Am Coll Cardiol. 1998;31:1591–1597
  33. Jourdain P, Joundeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure. J Am Coll Cardiol. 2007;49:1733–1739
  34. Sato Y, Kuwabara Y, Taniguchi R, et al. Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin. Int J Cardiol. 2008;126:171–176
  35. Costello-Boerrigter LC, Boerrigter G, Redfield MM, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol. 2006;47:345–353
  36. Luchner A, Hengstenberg C, Lowel H, Riegger GAJ, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension. 2005;46:118–123
  37. Goei D, Schouten O, Boersma E, et al. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol. 2008;101:122–126
  38. Bruch C, Reinecke H, Stypmann J, et al. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart disease. J Heart Lung Transplant. 2006;25:1135–1141

PII: S0167-5273(08)00615-3

doi: 10.1016/j.ijcard.2008.04.032

International Journal of Cardiology
Volume 136, Issue 2 , Pages 144-150 , 14 August 2009

Article Tools

* Image Usage & Resolution